Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 65 years old
- People without severe hearing or vision problems
- People who can speak and understand Turkish
- People who are easy to communicate with
- People experiencing acute coronary syndrome (a serious heart condition) for the first time
- People who have decided to begin treatment with a medication called ticagrelor
- People who are able to follow and adapt to their treatment plan
- People who have chosen to volunteer to take part in the research
Who may not be able to join:
- People who have any condition that makes communication difficult — whether cognitive, emotional, or verbal
- People with obstructive sleep abnormalities (confirm with trial site)
- People with a disease that affects breathing or lung function, such as stage IV cancer, asthma, COVID-19, lung cancer, fluid on the lungs, chronic obstructive pulmonary disease (COPD), high blood pressure in the lungs, pulmonary embolism, pneumonia, or bronchitis
- People with metabolic abnormalities (problems with the body's chemical processes — confirm with trial site)
- People who needed a breathing tube inserted after a procedure
- People who have previously been treated with ticagrelor
- People who have a blood oxygen level below 95%
- People who have experienced a cardiac arrest
- People who would not be able to meet the requirements of the study
- People with life-threatening conditions
- People who choose not to volunteer to participate
- People who decide to leave the study after it has begun
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +905556177281
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of ticagrelor-associated dyspnea
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.